Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

FDA approves entry of R-Tech ophthalmic solution into Phase I/II trials The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials. Drug Research > Drug Delivery > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

BASF, Dyadic enter into non-exclusive research, license agreement
20 May 2013 | By PBR Staff Writer
BASF and Dyadic International have entered into a non-exclusive worldwide research and license agreement.
Production & Manufacturing > Fine & Speciality Chemicals > News
Cempra, Toyama Chemical sign exclusive license, development agreement for solithromycin
15 May 2013 | By PBR Staff Writer
Cempra, a clinical-stage pharmaceutical company, has signed an exclusive license and development agreement for solithromycin with Toyama Chemical, a subsidiary of Fujifilm Holdings in Japan.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

China State and Food Administration grants GMP certificate to Sinovac Beijing
24 May 2013 | By PBR Staff Writer
The China State and Food Administration (CFDA) has granted the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) to Sinovac Beijing under the new GMP guidelines.
Production & Manufacturing > Process & Production > News
Agilent, University of Rouen, BTI collaborate to analyze biologics and vaccines
23 May 2013 | By PBR Staff Writer
Agilent Technologies, the University of Rouen's Glyco-MEV laboratory and Bioprocessing Technology Institute (BTI) at Singapore's Agency for Science, Technology and Research (A*STAR), have signed a memorandum of understanding (MoU) to help analyze biologics and vaccines.
Production & Manufacturing > Process & Production > News

OTC

PuraMed confirms LipiGesic M migrane treatment as "robust efficacy"
23 May 2013 | By PBR Staff Writer
Over-the-counter (OTC) medicinal and healthcare products developer PuraMed BioScience has unveiled the results of clinical trials that found its migraine medication product, LipiGesic M, has "robust efficacy."
Production & Manufacturing > OTC > News
US Organic Group develops over-the-counter organic anti-itch ointment
22 May 2013 | By PBR Staff Writer
US Organic Group has developed an over-the-counter organic anti-itch ointment, Anti Itchbalm, for itchy skin.
Production & Manufacturing > OTC > News

Manufacturing

Nordion agrees to sell Targeted Therapies business to BTG
24 May 2013 | By PBR Staff Writer
Pharmaceutical and medical-device maker Nordion has signed an agreement to sell its Targeted Therapies business to international specialist healthcare company, BTG, for $200m in cash.
Production & Manufacturing > Manufacturing > News
MedVantx completes expansion of home delivery platform
24 May 2013 | By PBR Staff Writer
MedVantx, a provider of consumer medication management and delivery services, has completed expansion of its home delivery platform to manage $1.5bn in prescription medications.
Production & Manufacturing > Manufacturing > News